{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T22:42:53Z","timestamp":1779144173750,"version":"3.51.4"},"reference-count":26,"publisher":"Scientific Scholar","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol Venereol Leprol"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/0378-6323.188655","type":"journal-article","created":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T09:54:21Z","timestamp":1471514061000},"page":"154","source":"Crossref","is-referenced-by-count":15,"title":["The effect of statins on severity of psoriasis: A systematic review"],"prefix":"10.25259","volume":"83","author":[{"given":"Ravi","family":"Ramessur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipender","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0378-6323.188655-1","first-page":"314","volume-title":"Psoriasis \u2013 Epidemiology and clinical spectrum","author":"Christophers","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/0378-6323.188655-2","first-page":"485","volume-title":"Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment","author":"Koo","year":"1996","journal-title":"Dermatol Clin"},{"key":"key-10.4103\/0378-6323.188655-3","first-page":"347","volume-title":"Heart disease in psoriasis","author":"Kremers","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.188655-4","first-page":"e6712","volume-title":"Assessment and management of psoriasis: Summary of NICE guidance.BMJ","author":"Samarasekera","year":"2012","journal-title":""},{"key":"key-10.4103\/0378-6323.188655-5","first-page":"333","volume-title":"Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): The correlation between disease severity and psychological burden in patients treated with biological therapies","author":"Mattei","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0378-6323.188655-6","first-page":"S27","volume-title":"Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase","author":"Istvan","year":"2002","journal-title":"Am Heart J"},{"key":"key-10.4103\/0378-6323.188655-7","first-page":"664","volume-title":"Statins: The drugs for the 21st century?","author":"Ginter","year":"2009","journal-title":"Bratisl Lek Listy"},{"key":"key-10.4103\/0378-6323.188655-8","first-page":"603","volume-title":"Targeting inflammation to slow or delay functional decline: Where are we?","author":"Corsonello","year":"2010","journal-title":"Biogerontology"},{"key":"key-10.4103\/0378-6323.188655-9","first-page":"683","volume-title":"Risk of bias reporting in Cochrane systematic reviews","author":"Hopp","year":"2015","journal-title":"Int J Nurs Pract"},{"key":"key-10.4103\/0378-6323.188655-10","unstructured":"Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011."},{"key":"key-10.4103\/0378-6323.188655-11","first-page":"57","volume-title":"Etanercept reduces symptoms and severity of psoriasis after cessation of cyclosporine therapy: Results of the SCORE study","author":"Micali","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/0378-6323.188655-12","first-page":"95","volume-title":"The efficacy of methotrexate plus pioglitazone vs.methotrexate alone in the management of patients with plaque-type psoriasis: A single-blinded randomized controlled trial","author":"Lajevardi","year":"2015","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0378-6323.188655-13","first-page":"224","volume-title":"Meta-analysis in clinical research","author":"L'Abb\u00e9","year":"1987","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/0378-6323.188655-14","first-page":"1045","volume-title":"Atorvastatin for the treatment of plaque-type psoriasis","author":"Faghihi","year":"2011","journal-title":"Pharmacotherapy"},{"key":"key-10.4103\/0378-6323.188655-15","first-page":"58","volume-title":"The remarkable beneficial effect of adding oral simvastatin to topical betamethasone for treatment of psoriasis: A double-blind, randomized, placebo-controlled study","author":"Naseri","year":"2010","journal-title":"Niger J Med"},{"key":"key-10.4103\/0378-6323.188655-16","first-page":"37","volume-title":"Possibilities of atorvastatin in complex management of extensive psoriasis in patients with arterial hypertension","author":"Vasiuk","year":"2010","journal-title":"Kardiologiia"},{"key":"key-10.4103\/0378-6323.188655-17","first-page":"529","volume-title":"Efficacy of simvastatin in plaque psoriasis: A pilot study","author":"Shirinsky","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.188655-18","first-page":"310","volume-title":"Efficacy and safety of simvastatin in chronic plaque psoriasis","author":"Aslam","year":"2013","journal-title":"J Pak Assoc Dermatol"},{"key":"key-10.4103\/0378-6323.188655-19","first-page":"411","volume-title":"Simvastatin in psoriasis: Ambiguous effects","author":"Colsman","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/0378-6323.188655-20","first-page":"124","volume-title":"Pharmacologic doses of lovastatin do not predictably affect the course of psoriasis","author":"Aronson","year":"1992","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.188655-21","first-page":"39","volume-title":"Sample size calculations for randomized controlled trials","author":"Wittes","year":"2002","journal-title":"Epidemiol Rev"},{"key":"key-10.4103\/0378-6323.188655-22","first-page":"982","volume-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","author":"Kjaergard","year":"2001","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/0378-6323.188655-23","first-page":"82","volume-title":"Gender and the treatment of immune-mediated chronic inflammatory diseases: Rheumatoid arthritis, inflammatory bowel disease and psoriasis: An observational study","author":"Lesuis","year":"2012","journal-title":"BMC Med"},{"key":"key-10.4103\/0378-6323.188655-24","first-page":"855","volume-title":"Statins inhibit chemotactic interaction between CCL20 and CCR6 in vitro: Possible relevance to psoriasis treatment","author":"Kim","year":"2011","journal-title":"Exp Dermatol"},{"key":"key-10.4103\/0378-6323.188655-25","first-page":"390","volume-title":"Comparative tolerability and harms of individual statins: A study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials","author":"Naci","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"key-10.4103\/0378-6323.188655-26","first-page":"1220","volume-title":"Adverse effects of statins \u2013 Myths and reality","author":"\u0160imic","year":"2015","journal-title":"Curr Pharm Des"}],"container-title":["Indian Journal of Dermatology, Venereology, and Leprology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T10:43:46Z","timestamp":1611917026000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijdvl.com\/the-effect-of-statins-on-severity-of-psoriasis-a-systematic-review\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"alternative-id":["188655"],"URL":"https:\/\/doi.org\/10.4103\/0378-6323.188655","relation":{},"ISSN":["0378-6323"],"issn-type":[{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}